MLX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.108000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.050390E-01
Normal-vs-Stage2
3.137600E-01
Normal-vs-Stage3
7.706000E-01
Normal-vs-Stage4
3.018100E-02
Stage1-vs-Stage2
6.418000E-01
Stage1-vs-Stage3
1.054850E-01
Stage1-vs-Stage4
2.616400E-01
Stage2-vs-Stage3
1.307390E-01
Stage2-vs-Stage4
1.445630E-01
Stage3-vs-Stage4
5.003900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.226400E-01
Normal-vs-AfricanAmerican
1.374980E-01
Normal-vs-Asian
6.111400E-01
Caucasian-vs-AfricanAmerican
3.755000E-01
Caucasian-vs-Asian
5.948200E-01
AfricanAmerican-vs-Asian
3.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.432000E-01
Normal-vs-Female
2.860400E-01
Male-vs-Female
8.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.176000E-01
Normal-vs-Age(41-60Yrs)
1.747980E-01
Normal-vs-Age(61-80Yrs)
4.160000E-01
Normal-vs-Age(81-100Yrs)
2.957200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.213000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.278000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.934600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.444030E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.993600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.671200E-01
Normal-vs-Daily Drinker
6.918600E-01
Normal-vs-Weekly Drinker
4.945000E-01
Normal-vs-Occasional Drinker
1.227830E-01
Normal-vs-Social Drinker
1.469420E-01
Non Drinker-vs-Daily Drinker
5.902400E-01
Non Drinker-vs-Weekly Drinker
7.063800E-01
Non Drinker-vs-Occasional Drinker
1.166420E-01
Non Drinker-vs-Social Drinker
4.083400E-01
Daily Drinker-vs-Weekly Drinker
4.117200E-01
Daily Drinker-vs-Occasional Drinker
3.029900E-02
Daily Drinker-vs-Social Drinker
1.770250E-01
Weekly Drinker-vs-Occasional Drinker
3.583200E-01
Weekly Drinker-vs-Social Drinker
8.315600E-01
Occasional Drinker-vs-Social Drinker
3.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.956000E-02
Normal-vs-Grade 2
1.849800E-02
Normal-vs-Grade 3
1.842000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.759900E-02
Grade 1-vs-Grade 3
2.261000E-01
Grade 1-vs-Grade 4
7.956000E-02
Grade 2-vs-Grade 3
6.571000E-01
Grade 2-vs-Grade 4
1.849800E-02
Grade 3-vs-Grade 4
1.842000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.740800E-01
Normal-vs-NonDiabetic
2.483800E-01
Diabetic-vs-NonDiabetic
6.926200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.409640E-01
Normal-vs-NoPancreatitis
3.949600E-01
Pancreatitis-vs-NoPancreatitis
1.317830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.297400E-01
Normal-vs-N1
3.464800E-01
N0-vs-N1
5.710000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.758480E-04
Normal-vs-TP53-NonMutant
6.577100E-03
TP53-Mutant-vs-TP53-NonMutant
9.555700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
